Cell Therapeutics, Inc. (CTIC) announced the results from its Annual Meeting of Shareholders held on October 20, 2009.
At the meeting, shareholders elected Richard Love, Mary Mundinger, and Jack Singer to serve on the Company's Board of Directors until the 2012 Annual Meeting. Shareholders also approved the proposals to increase the number of shares available for issuance under its 2007 Equity Incentive Plan, increase the number of shares available for issuance under its 2007 Employee Purchase Plan and issue shares of common stock in lieu of future milestone payments related to the Company's drug candidate brostallicin.
Further, shareholders ratified the selection of Stonefield Josephson, Inc. as the Company's independent auditors for the year ending December 31, 2009.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.